CN103520684B - Traditional Chinese medicine compound for reducing blood sugar - Google Patents
Traditional Chinese medicine compound for reducing blood sugar Download PDFInfo
- Publication number
- CN103520684B CN103520684B CN201310492565.1A CN201310492565A CN103520684B CN 103520684 B CN103520684 B CN 103520684B CN 201310492565 A CN201310492565 A CN 201310492565A CN 103520684 B CN103520684 B CN 103520684B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- compound
- medicine compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种降血糖的中药复合物,其由下述重量配比的原料制备而得,蒲公英30份、猪苓30份、白扁豆27份、马齿苋27份、枳壳25份、合欢皮25份、麦冬23份、白茅根23份、莱菔子20份、当归20份、桑叶20份、石斛18份、粳米15份、甘草15份、天花粉15份、桂枝15份、炮姜13份、黄芪10份、山茱萸10份、覆盆子9份、玉竹9份、桃仁9份、葛根7份、熟地黄7份、五味子5份、人参5份、知母5份、甜瓜子5份。该中药复合物针对糖尿病的治疗疗程短,总有效率高,愈后不易复发,并且工艺简单,降低了生产成本,减轻了患者的经济负担。The invention relates to a traditional Chinese medicine compound for lowering blood sugar, which is prepared from the following raw materials in proportion by weight: 30 parts of dandelion, 30 parts of polyporus, 27 parts of white hyacinth bean, 27 parts of purslane, 25 parts of Fructus aurantii, 25 parts of Albizia bark, 23 parts of Ophiopogon japonicus, 23 parts of Imperata rhizome, 20 parts of radish seed, 20 parts of angelica, 20 parts of mulberry leaves, 18 parts of dendrobium, 15 parts of japonica rice, 15 parts of licorice, 15 parts of trichosanthin, 15 parts of cassia twig, 13 parts of ginger, 10 parts of astragalus, 10 parts of dogwood, 9 parts of raspberry, 9 parts of Polygonatum odoratum, 9 parts of peach kernel, 7 parts of kudzu root, 7 parts of rehmannia glutinosa, 5 parts of schisandra, 5 parts of ginseng, 5 parts of anemarrhena, melon Sub 5 servings. The traditional Chinese medicine compound has a short treatment course for diabetes, a high total effective rate, is not easy to relapse after healing, has a simple process, reduces production costs, and lightens the economic burden of patients.
Description
技术领域technical field
本发明属于医药技术领域,具体涉及一种降血糖的中药复合物以及制备方法。The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine compound for lowering blood sugar and a preparation method thereof.
背景技术Background technique
糖尿病(diabetes)是一种常见的内分泌代谢性疾病。糖尿病患者的症状如:多饮、多尿、多食、消瘦等症状,严重者发生酮症酸中毒及昏迷,且糖尿病因长期高血糖等而导致动脉硬化和微血管病变,发生早而严重的心、脑、肾、眼、神经、皮肤等器官受损,出现相应脏器的症状及体征。糖尿病常因机体免疫力和防御机能下降,易合并皮肤粘膜及软组织感染性疾病(疖、痈、蜂窝组织炎、坏疽)、呼吸道感染(肺炎、肺结核),真菌等感染而出现相应的症状及体征。糖尿病的确诊标准为:空腹血糖≥7.0mmol/L(126mg/dl),任何时候血糖≥11.1mmol/L(200mg/dl)可确诊为糖尿病。空腹血糖为临界值时,口服葡萄糖耐量试验(OGTT),即服糖后2小时内血糖≥11.1mmol/L(200mg/dl)。临床上以高血糖为主要特点,典型病例可出现多尿、多饮、多食、消瘦等表现,即“三多一少”症状,临床观察胰岛素抵抗普遍存在于II型糖尿病中,高达90%左右。II型糖尿病的早期,通常可以通过单纯饮食控制、增加体育锻炼或应用磺脲类药物使血糖得到控制。但不幸的是,β细胞功能紊乱导致胰岛素分泌受损呈进行性恶化。患者将需要胰岛素单独或与其他口服药联合应用的治疗策略。Diabetes is a common endocrine and metabolic disease. Symptoms of diabetic patients include: polydipsia, polyuria, polyphagia, weight loss and other symptoms. In severe cases, ketoacidosis and coma occur. Moreover, diabetes can cause arteriosclerosis and microvascular disease due to long-term high blood sugar, and early and serious heart disease. , brain, kidney, eyes, nerves, skin and other organs are damaged, and symptoms and signs of corresponding organs appear. Diabetes often has corresponding symptoms and signs due to the decline of the body's immunity and defense function, and it is easy to be combined with skin, mucous membrane and soft tissue infectious diseases (furuncle, carbuncle, cellulitis, gangrene), respiratory tract infection (pneumonia, tuberculosis), fungal infection, etc. . The diagnostic criteria for diabetes are: fasting blood glucose ≥ 7.0mmol/L (126mg/dl), and blood glucose ≥ 11.1mmol/L (200mg/dl) at any time can be diagnosed as diabetes. When the fasting blood glucose is the critical value, oral glucose tolerance test (OGTT) means the blood glucose ≥ 11.1mmol/L (200mg/dl) within 2 hours after taking the sugar. Clinically, hyperglycemia is the main feature. In typical cases, symptoms such as polyuria, polydipsia, polyphagia, and weight loss may appear, that is, symptoms of "three excesses and one deficiency". Clinical observations show that insulin resistance is common in type II diabetes, up to 90% about. In the early stage of type 2 diabetes, blood sugar can usually be controlled through simple diet control, increased physical exercise or application of sulfonylurea drugs. Unfortunately, impaired insulin secretion is progressively worsened by β-cell dysfunction. Patients will require a treatment strategy of insulin alone or in combination with other oral agents.
西药对本病的治疗:多用双胍类、磺脲类或胰岛素等,不易控制空腹及餐后血糖,使血糖波动幅度大。尤其是注射胰岛素者,其注射剂量、时间与进餐的成分、质量、时间的关系十分密切,不易掌握,真正能按要求做到的人很少。况且本病的病因和病机复杂,至今仍未完全明了,更缺乏行之有效的针对病因治疗的方法。其并发症甚多,是引起糖、脂肪、蛋白质等代谢紊乱,导致心、脑、肾重要脏器损害及大血管、微血管损伤的罪魁祸首。The treatment of this disease with western medicine: biguanides, sulfonylureas or insulin are often used, which are difficult to control fasting and postprandial blood sugar, resulting in large fluctuations in blood sugar. Especially for those who inject insulin, the injection dose and time are closely related to the ingredients, quality and time of the meal, which is difficult to master, and few people can really do it according to the requirements. Moreover, the etiology and pathogenesis of this disease are complicated, and they are not fully understood so far, and there is a lack of effective methods for the treatment of the cause. Its complications are many, and it is the chief culprit that causes metabolic disorders such as sugar, fat, and protein, and causes damage to important organs of the heart, brain, and kidney, as well as damage to large blood vessels and microvessels.
与西药相比,中草药对胃、肝、肾有很好的保护作用,而且效果平稳有效,适用人群广,更无西药的毒副作用。祖国医学认为:糖尿病为“消渴”范畴。消渴病名始见于《内经》。又有“肺消”,“膈消”,“消中”等。其病因病机主要有:嗜酒辛辣肥甘厚味,五志过极、久病或热病之后及先天禀赋不足或肥胖等导致阴津亏损、血脉瘀滞、燥热偏盛等。临床以多饮、多食、多尿、形体消瘦或尿有甜味为特征的一种疾病。要在肺、胃、肾,基本病机为阴津亏耗,燥热偏盛。消渴日久,病情失控,则阴损及阳,热灼津亏血瘀,而致气阴两伤,阴阳俱虚,络脉瘀阻,经脉失养,气血逆乱,脏腑器官受损而出现疖、痈、眩晕、胸痹、耳聋、目盲、肢体麻疼、下肢坏疽、肾衰水肿、中风昏迷等兼症。中国传统医学的消渴症始见于《黄帝内经·奇病论》,名为消渴。中医所论消渴,肺热伤津、口渴多饮为上消;胃火炙盛、消谷善饥为中消;肾不摄水、小便频数为下消。肺燥、胃热、肾虚并见,或有侧重,而成消渴,缺一而不能成此症。Compared with western medicine, Chinese herbal medicine has a good protective effect on the stomach, liver and kidney, and the effect is stable and effective. It is suitable for a wide range of people and has no toxic side effects of western medicine. Motherland medicine thinks: Diabetes belongs to " quench one's thirst " category. Diabetes disease name first appeared in "Internal Classics". There are also "Lung Xiao", "Green Xiao", "Xiaozhong" and so on. Its etiology and pathogenesis mainly include: alcoholism, spicy, fat, sweet and thick taste, excessive five senses, chronic illness or febrile disease, insufficient congenital endowment or obesity, etc., leading to loss of yin and fluid, blood stasis, excessive dryness and heat, etc. Clinically, it is a disease characterized by polydipsia, polyphagia, polyuria, emaciation, or sweet-smelling urine. In the lungs, stomach, and kidneys, the basic pathogenesis is the depletion of yin and fluid, and the excess of dryness and heat. Prolonged thirst and out of control of the disease will lead to yin damage and yang, heat burns body fluid and blood stasis, resulting in damage to both qi and yin, deficiency of both yin and yang, stasis of collaterals, loss of nourishment of meridians, disorder of qi and blood, damage to viscera and organs Furuncle, carbuncle, dizziness, chest pain, deafness, blindness, limb numbness, gangrene of lower limbs, kidney failure edema, stroke coma and other concurrent symptoms appear. Diabetes in traditional Chinese medicine was first seen in "The Yellow Emperor's Canon of Strange Diseases", and it is called Diabetes. According to traditional Chinese medicine, quenching one’s thirst, lung heat injuring body fluid, thirsty and excessive drinking is the upper disappearance; stomach fire is abundant, eliminating grains and hunger is the middle disappearance; kidneys do not absorb water and frequent urination is the lower disappearance. Dryness of the lung, stomach heat, and kidney deficiency occur together, or they may be emphasized, resulting in diabetes, and lack of one cannot cause this disease.
本发明在现有技术的基础上进一步组配新方,提供一种工艺简单,成本低廉,药物来源广泛用于降血糖的中药复合物。On the basis of the prior art, the present invention further assembles a new prescription, and provides a traditional Chinese medicine compound with simple process, low cost and widely used drug source for lowering blood sugar.
发明内容Contents of the invention
本发明的目的是在现有技术的基础上进一步组配新方,提供一种工艺简单,成本低廉,滋阴补肾,清热除烦,生津止渴,益气降糖,补肾健脾,活血化瘀,药物来源广泛用于降血糖的中药复合物。The purpose of the present invention is to further assemble a new prescription on the basis of the prior art, to provide a simple process, low cost, nourishing yin and kidney, clearing away heat and trouble, promoting body fluid and quenching thirst, nourishing qi and lowering sugar, tonifying kidney and spleen, promoting blood circulation Blood stasis, drug sources are widely used in Chinese medicine compounds for lowering blood sugar.
本申请发明人结合前人秘方及多年的行医实践,通过对传统中药的研究,并结合辩证论证,多方收集众家之长,寻求最佳治疗方案,按中医理论组方,采用纯天然中药原料,经系统研究、科学配伍,结合传统中医技术精心配制成本发明的降血糖的中药复合物,对糖尿病有较佳的功效。The inventor of the present application combined the predecessors' secret recipes and many years of medical practice, through the research on traditional Chinese medicine, combined with dialectical argumentation, collected the strengths of many families in many ways, sought the best treatment plan, formulated prescriptions according to the theory of traditional Chinese medicine, and used pure natural Chinese medicine raw materials , through systematic research, scientific compatibility, combined with traditional Chinese medicine technology, the traditional Chinese medicine compound for lowering blood sugar of the present invention is carefully prepared, which has a better effect on diabetes.
为实现上述目的,本发明采用的技术方案如下:To achieve the above object, the technical scheme adopted in the present invention is as follows:
一种降血糖的中药复合物,其由下述原料制备而得,A traditional Chinese medicine compound for lowering blood sugar, which is prepared from the following raw materials,
蒲公英30份、猪苓30份、白扁豆27份、马齿苋27份、枳壳25份、30 parts of dandelion, 30 parts of Polyporus, 27 parts of white lentils, 27 parts of purslane, 25 parts of Citrus aurantium,
合欢皮25份、麦冬23份、白茅根23份、莱菔子20份、当归20份、25 parts of acacia skin, 23 parts of Ophiopogon japonicus, 23 parts of Imperata rhizome, 20 parts of radish seed, 20 parts of angelica,
桑叶20份、石斛18份、粳米15份、甘草15份、天花粉15份、20 parts of mulberry leaves, 18 parts of dendrobium, 15 parts of japonica rice, 15 parts of licorice, 15 parts of trichosanthes,
桂枝15份、炮姜13份、黄芪10份、山茱萸10份、覆盆子9份、15 parts of Guizhi, 13 parts of Pao Jiang, 10 parts of Astragalus, 10 parts of Dogwood, 9 parts of Raspberry,
玉竹9份、桃仁9份、葛根7份、熟地黄7份、五味子5份、9 parts of Polygonatum odoratum, 9 parts of peach kernel, 7 parts of kudzu root, 7 parts of rehmannia glutinosa, 5 parts of schisandra,
人参5份、知母5份、甜瓜子5份。5 parts of ginseng, 5 parts of Anemarrhena, and 5 parts of melon seeds.
本发明的降血糖的中药复合物可采用一般方法将处方中的各味药材按比例进行配伍,按现有制剂工艺制成各种临床适用剂型,所用的各味药材均为市售的经过检验合格的中药材。The traditional Chinese medicine compound for hypoglycemia of the present invention can adopt the general method to carry out the compatibility of each medicinal material in the prescription in proportion, and make various clinically applicable dosage forms according to the existing preparation process, and the various medicinal materials used are commercially available and tested Qualified Chinese medicinal materials.
本发明的降血糖的中药复合物其制备及服用方法为:取上述重量份的原料药(配比单位:克)制备胶囊,具体操作为:The method for preparing and taking the Chinese medicine compound for lowering blood sugar of the present invention is as follows: take the raw material drug (proportioning unit: gram) of the above-mentioned parts by weight to prepare capsules, and the specific operations are as follows:
1)称取各原料药,备用;1) Take each bulk drug and set aside;
2)取蒲公英、猪苓、白扁豆、马齿苋、白茅根、莱菔子、当归、石斛、粳米、葛根、熟地黄、五味子、人参、知母混合均匀,加3倍重量的水武火煮沸,然后文火煎煮1小时,过滤收集滤液和滤渣;往滤渣中添加水,以没过滤渣为准,武火煮沸,然后文火煎煮30分钟,过滤收集滤液;合并上述两次滤液,冷却后,浓缩成密度为1.1-1.2g/ml的浸膏;80℃烘干后,粉碎成粉末,即为复合物A;2) Take dandelion, polyporus, white lentils, purslane, coriander root, radish seed, angelica, dendrobium, japonica rice, kudzu root, rehmannia glutinosa, schisandra, ginseng, and anemarrhena, add 3 times the weight of water and boil on high heat, Then simmer for 1 hour, filter and collect the filtrate and filter residue; add water to the filter residue, subject to no filter residue, boil with high heat, then simmer for 30 minutes, filter and collect the filtrate; combine the above two filtrates, after cooling, concentrate Form an extract with a density of 1.1-1.2g/ml; after drying at 80°C, crush it into powder, which is Compound A;
2)取剩余原料(即枳壳、合欢皮、麦冬、桑叶、甘草、天花粉、桂枝、炮姜、黄芪、山茱萸、覆盆子、玉竹、桃仁、甜瓜子)加70%乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液,滤过,浓缩成相对密度为1.2的浸膏,干燥后粉碎,得复合物B2) Take the remaining raw materials (i.e. Citrus aurantium, Albizia juniper, Ophiopogon japonicus, mulberry leaves, licorice, trichosanthum pollen, cassia twig, ginger, astragalus, dogwood, raspberry, Polygonatum odoratum, peach kernel, melon seeds) and soak in 70% ethanol for 0.5 -1.5 hours, extract twice, 1-2 hours each time, combine the extracts, filter, concentrate into an extract with a relative density of 1.2, dry and pulverize to obtain complex B
3)将复合物A和复合物B混合搅拌均匀,灭菌消毒制得胶囊剂产品,口服一日三次,饭前半小时服用,每次0.5g,两周为一个疗程。3) Mix compound A and compound B evenly, sterilize and prepare a capsule product, take orally three times a day, half an hour before meals, 0.5g each time, two weeks as a course of treatment.
本发明药物的组分均采用天然的中药原料,其配制简便,药源广泛,成本低廉,其遵循中医的处方用药原则,诸药合用,相得益彰,本发明制剂服用量小,药物有效成分易于释放,吸收快,生物利用度高,使药效能够充分发挥,经临床应用验证,其疗效显著可靠,药性平和,未出现毒副作用,应用前景广阔。The components of the medicine of the present invention are all made of natural traditional Chinese medicine raw materials, which are easy to prepare, have a wide range of medicine sources, and are low in cost. They follow the principles of prescription medication in traditional Chinese medicine, and all medicines are used in combination to complement each other. , fast absorption, high bioavailability, so that the efficacy of the drug can be fully exerted. It has been verified by clinical application that its curative effect is remarkable and reliable, the property of the drug is mild, and there is no toxic and side effect, and the application prospect is broad.
服药期间忌食辛辣及寒凉食物,避免情志刺激,生活要有规律。Avoid spicy and cold food while taking the medicine, avoid emotional stimulation, and have a regular life.
本发明中药组合物及其制备方法的优良效果在于:The excellent effect of Chinese medicine composition of the present invention and preparation method thereof is:
1.本发明的药剂由纯中药制成,各组分符合药典法相关规定,利用各味中药的配伍作用,不含化工成分,不含激素,无毒副作用,标本兼治,达到更好的降血糖的作用;1. The medicament of the present invention is made of pure Chinese medicine, and each component complies with the relevant provisions of the Pharmacopoeia Law. It utilizes the compatibility of various Chinese medicines, does not contain chemical ingredients, does not contain hormones, has no toxic and side effects, and treats both symptoms and root causes to achieve better reduction. the effect of blood sugar;
2.该药剂疗程短,总有效率高,愈后不易复发;2. The drug has a short course of treatment, a high total effective rate, and is not easy to relapse after recovery;
3.本发明的工艺简单,降低了生产成本,减轻了患者的经济负担。3. The process of the present invention is simple, which reduces the production cost and the economic burden of patients.
具体实施方式detailed description
以下通过具体的实施例来详尽解释本发明,但是并不作为对本发明内容的限制。Hereinafter, the present invention is explained in detail through specific examples, but not as a limitation to the content of the present invention.
实施例1Example 1
一种降血糖的中药复合物,其由下述重量份的原料制备而得A traditional Chinese medicine compound for lowering blood sugar, which is prepared from the following raw materials in parts by weight
蒲公英30份、猪苓30份、白扁豆27份、马齿苋27份、枳壳25份、30 parts of dandelion, 30 parts of Polyporus, 27 parts of white lentils, 27 parts of purslane, 25 parts of Citrus aurantium,
合欢皮25份、麦冬23份、白茅根23份、莱菔子20份、当归20份、25 parts of acacia skin, 23 parts of Ophiopogon japonicus, 23 parts of Imperata rhizome, 20 parts of radish seed, 20 parts of angelica,
桑叶20份、石斛18份、粳米15份、甘草15份、天花粉15份、20 parts of mulberry leaves, 18 parts of dendrobium, 15 parts of japonica rice, 15 parts of licorice, 15 parts of trichosanthes,
桂枝15份、炮姜13份、黄芪10份、山茱萸10份、覆盆子9份、15 parts of Guizhi, 13 parts of Pao Jiang, 10 parts of Astragalus, 10 parts of Dogwood, 9 parts of Raspberry,
玉竹9份、桃仁9份、葛根7份、熟地黄7份、五味子5份、9 parts of Polygonatum odoratum, 9 parts of peach kernel, 7 parts of kudzu root, 7 parts of rehmannia glutinosa, 5 parts of schisandra,
人参5份、知母5份、甜瓜子5份。5 parts of ginseng, 5 parts of Anemarrhena, and 5 parts of melon seeds.
本发明的药物组合物其制备及服用方法为:取上述重量份数的原料药(配比单位:克)制备胶囊,具体操作为:Its preparation and taking method of the pharmaceutical composition of the present invention are: take the crude drug (proportioning unit: gram) of above-mentioned parts by weight to prepare capsules, and concrete operation is:
1)称取各原料药,备用;1) Take each bulk drug and set aside;
2)取蒲公英、猪苓、白扁豆、马齿苋、白茅根、莱菔子、当归、石斛、粳米、葛根、熟地黄、五味子、人参、知母混合均匀,加3倍重量的水武火煮沸,然后文火煎煮1小时,过滤收集滤液和滤渣;往滤渣中添加水,以没过滤渣为准,武火煮沸,然后文火煎煮30分钟,过滤收集滤液;合并上述两次滤液,冷却后,浓缩成密度为1.1g/ml的浸膏;80℃烘干后,粉碎成粉末,即为复合物A;2) Take dandelion, polyporus, white lentils, purslane, coriander root, radish seed, angelica, dendrobium, japonica rice, kudzu root, rehmannia glutinosa, schisandra, ginseng, and anemarrhena, add 3 times the weight of water and boil on high heat, Then simmer for 1 hour, filter and collect the filtrate and filter residue; add water to the filter residue, subject to no filter residue, boil with high heat, then simmer for 30 minutes, filter and collect the filtrate; combine the above two filtrates, after cooling, concentrate Form an extract with a density of 1.1g/ml; after drying at 80°C, crush it into powder, which is Compound A;
2)取剩余原料(即枳壳、合欢皮、麦冬、桑叶、甘草、天花粉、桂枝、炮姜、黄芪、山茱萸、覆盆子、玉竹、桃仁、甜瓜子)加70%乙醇浸泡1小时,提取两次,每次1小时,合并提取液,滤过收集滤液,将滤液浓缩成相对密度为1.2的浸膏,干燥后粉碎,得复合物B2) Take the remaining raw materials (i.e. Citrus aurantium, Albizia Julibrissin, Ophiopogon japonicus, mulberry leaves, licorice, TCS, cinnamon twig, ginger, astragalus, dogwood, raspberry, Polygonatum odoratum, peach kernel, melon seeds) and soak in 70% ethanol for 1 hour, extract twice, each time for 1 hour, combine the extracts, collect the filtrate by filtration, concentrate the filtrate into an extract with a relative density of 1.2, and pulverize after drying to obtain complex B
3)将复合物A和复合物B混合搅拌均匀,灭菌消毒制得胶囊剂产品,口服一日三次,饭前半小时服用,每次0.5g,两周为一个疗程。3) Mix compound A and compound B evenly, sterilize and prepare a capsule product, take orally three times a day, half an hour before meals, 0.5g each time, two weeks as a course of treatment.
实施例2Example 2
动物学实验zoology experiment
试验流程:Wistar大鼠60只,雌雄各半,山东大学第一附属医院动物中心提供。大鼠在动物房喂养5天后,随机抽取10只作为正常对照组喂以普通维持饲料。高糖高脂饲料配方参见文献“高糖高脂饲料对Wistar大鼠生长和糖脂代谢的影响”,《卫生研究》2009年第06期。其余50只采用高糖高脂饲料喂养6周。6周后大鼠经禁食24h后,链脲佐菌素静脉注射20mg/Kg,每两天一次,使用两次后,血糖血脂居高不下者为造模成功。选取造模成功的大鼠30只,随机分为3组,每组10只,即空白组(不施用任何药物)、本发明实施例1药物组10mg/Kg、对照药物组:施用二甲双胍(10mg/kg),施用方式均为口服,每天早晚饭前半时服用。连续服用两周后检测;停药10天后再次监测血糖。经检测:对照药物组和本发明药物组空腹血糖均有明显下降,本发明药物明显好于对照药物组,停药十天后,本发明药物组基本没有出现反弹,具体参见下表1。Test procedure: 60 Wistar rats, half male and half male, were provided by the Animal Center of the First Affiliated Hospital of Shandong University. After the rats were fed for 5 days in the animal room, 10 rats were randomly selected as the normal control group and fed with ordinary maintenance feed. For the formula of high-sugar and high-fat feed, please refer to the literature "Effect of high-sugar and high-fat feed on growth and glucose and lipid metabolism of Wistar rats", "Health Research" 2009 No. 06. The remaining 50 were fed with high-sugar and high-fat diet for 6 weeks. After 6 weeks of fasting for 24 hours, the rats were intravenously injected with streptozotocin 20mg/Kg, once every two days. Choose 30 rats with successful modeling, and be divided into 3 groups at random, 10 in every group, i.e. blank group (do not use any medicine), the medicine group 10mg/Kg of embodiment 1 of the present invention, control medicine group: use metformin (10mg /kg), the way of administration is oral, every morning and evening before meals. Test after two weeks of continuous use; monitor blood sugar again after 10 days of drug withdrawal. After testing: both the control drug group and the drug group of the present invention had significantly decreased fasting blood sugar, and the drug of the present invention was significantly better than the control drug group. After ten days of drug withdrawal, the drug group of the present invention basically did not rebound. See Table 1 for details.
表1Table 1
实施例3Example 3
临床病例clinical case
资料与方法:一般资料门诊II型糖尿病患者共46例,其中男25例,女21例,患者年龄55~73岁,空腹血糖(FPG)以及餐后2h血糖(2hPG)均大幅升高。服用本发明实施例1制备的药物两个疗程后,检测上述生化指标。Materials and Methods: General Information There were 46 outpatients with type 2 diabetes mellitus, including 25 males and 21 females, aged 55-73 years, with significantly elevated fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG). After taking the medicine prepared in Example 1 of the present invention for two courses of treatment, the above biochemical indicators were detected.
治愈:FPG<6.1mmol/L,2h血糖(2hPG)<8.0mmol/L;Cured: FPG<6.1mmol/L, 2h blood glucose (2hPG)<8.0mmol/L;
有效:空腹血糖(FPG)、餐后2h血糖(2hPG)有所改善,但未达到正常水平;Effective: Fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG) have improved, but have not reached normal levels;
无效:空腹血糖(FPG)、餐后2h血糖(2hPG)均无明显改变;Ineffective: Fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG) did not change significantly;
治疗效果:治愈33例,有效12例,无效1例,总有效率为97%以上。Treatment effect: 33 cases were cured, 12 cases were effective, and 1 case was ineffective. The total effective rate was over 97%.
实施例4Example 4
典型病例Typical cases
陈某,男,47岁,乏力、气短、自汗,动则加重,口干舌燥,多饮多尿,五心烦热,大便秘结,腰膝酸软,舌淡或舌红暗。舌边有齿痕,苔薄白少津,脉细弱。空腹血糖9.4mmol/L,诊断为糖尿病2型。给予实施例1的中药复合物,服用2个疗程后,症状减轻,继续服用1个疗程巩固,空腹血糖小于7。半年后追访,血糖值正常。Chen, male, 47 years old, fatigue, shortness of breath, spontaneous sweating, aggravated by movement, dry mouth, polydipsia and polyuria, dysphoria and fever, constipation, soreness of waist and knees, pale or dark red tongue. There are tooth marks on the edge of the tongue, thin and white fur with little fluid, thready and weak pulse. Fasting blood glucose 9.4mmol / L, diagnosed as type 2 diabetes. Give the traditional Chinese medicine compound of embodiment 1, after taking 2 courses of treatment, symptom alleviates, continues to take 1 course of treatment and consolidates, and fasting blood sugar is less than 7. Follow-up visit after half a year, blood sugar level is normal.
宋某:女、61岁,患者3年前出现多饮、多尿、消瘦,在苍山县人民医院诊断为2型糖尿病。服用降糖药物,血糖仍控制不稳,时高时低,空腹血糖在15.8mmol/L左右。半年前双足趾出现针刺样疼痛。症见:双下肢麻木、双足趾针刺感、多饮、多尿、神疲乏力、气短、形体消瘦、便溏、舌红少津、苔薄黄、脉细数无力,给予实施例1制备的中药复合物,经治疗2个疗程后,双足趾刺痛感基本消失、麻木减轻、神疲乏力、气短等症状减轻、大便成形,血糖7.0mmol/L;治疗4个疗程后:双足趾刺痛感、麻木等消失,血糖稳定在5.6mmol/L左右。嘱继续服用1个疗程以巩固治疗。之后经多次随访,血糖稳定在6.0mmol/L以下、无复发。Song: female, 61 years old, the patient developed polydipsia, polyuria, and weight loss 3 years ago, and was diagnosed as type 2 diabetes in Cangshan County People's Hospital. Taking hypoglycemic drugs, the control of blood sugar is still unstable, sometimes high and sometimes low, and the fasting blood sugar is around 15.8mmol/L. Half a year ago, there was needle-like pain in both toes. Symptoms: numbness of both lower extremities, tingling sensation in both toes, polydipsia, polyuria, fatigue, shortness of breath, emaciation, loose stools, red tongue with less fluid, thin yellow fur, thready and weak pulse, given Example 1 The prepared traditional Chinese medicine compound, after 2 courses of treatment, the tingling sensation in both toes basically disappeared, the numbness, fatigue, shortness of breath and other symptoms were relieved, the stool was formed, and the blood sugar was 7.0mmol/L; after 4 courses of treatment: The tingling and numbness of the toes disappeared, and the blood sugar stabilized at around 5.6mmol/L. Advise to continue to take 1 course of treatment to consolidate treatment. After several follow-up visits, the blood sugar was stable below 6.0mmol/L and there was no recurrence.
上述数据对本发明的具体实施方式进行了详尽描述,但并非对本发明保护范围的限制,所属领域技术人员应该明白,在本发明的技术方案的基础上,本领域技术人员不需要付出创造性劳动即可做出的各种修改或变形仍在本发明的保护范围以内。The above data have described the specific implementation of the present invention in detail, but are not intended to limit the scope of protection of the present invention. Those skilled in the art should understand that on the basis of the technical solution of the present invention, those skilled in the art do not need to pay creative work. Various modifications or variations made are still within the protection scope of the present invention.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310492565.1A CN103520684B (en) | 2013-10-21 | 2013-10-21 | Traditional Chinese medicine compound for reducing blood sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310492565.1A CN103520684B (en) | 2013-10-21 | 2013-10-21 | Traditional Chinese medicine compound for reducing blood sugar |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103520684A CN103520684A (en) | 2014-01-22 |
| CN103520684B true CN103520684B (en) | 2015-08-12 |
Family
ID=49923271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310492565.1A Expired - Fee Related CN103520684B (en) | 2013-10-21 | 2013-10-21 | Traditional Chinese medicine compound for reducing blood sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103520684B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107281408A (en) * | 2017-07-31 | 2017-10-24 | 山东省科学院生物研究所 | A kind of hypoglycemic traditional Chinese medicine composition and preparation method thereof |
| CN108498563B (en) * | 2018-05-18 | 2020-10-23 | 广东药科大学 | Chitosan composition and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895547A (en) * | 2006-06-16 | 2007-01-17 | 魏四清 | Medicine for treating diabetes and its preparation |
| CN102988932A (en) * | 2012-10-27 | 2013-03-27 | 王勤 | Medicament for treating hypoglycemia and preparation method of medicament |
-
2013
- 2013-10-21 CN CN201310492565.1A patent/CN103520684B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895547A (en) * | 2006-06-16 | 2007-01-17 | 魏四清 | Medicine for treating diabetes and its preparation |
| CN102988932A (en) * | 2012-10-27 | 2013-03-27 | 王勤 | Medicament for treating hypoglycemia and preparation method of medicament |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103520684A (en) | 2014-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109674958B (en) | Traditional Chinese medicine composition with effect of reducing uric acid and preparation method and application thereof | |
| CN100488552C (en) | Chinese medicine composition for treating arthritis or gout and preparing method thereof | |
| CN101780227B (en) | Traditional Chinese medicine composition for treating acute stroke and preparation method thereof | |
| CN103933487A (en) | Compound traditional Chinese medicament for treating depression | |
| CN103520684B (en) | Traditional Chinese medicine compound for reducing blood sugar | |
| CN117959394B (en) | Use of Shenqi Tongmai preparation in preparing medicine for preventing and treating diabetic neuropathy | |
| CN103536879B (en) | A kind of pharmaceutical composition and preparation method for the treatment of diabetes | |
| CN102441064B (en) | Traditional Chinese medicine composition and its preparation for treating diabetes | |
| CN101933963A (en) | A nasal in situ gel for treating headaches | |
| CN103566349B (en) | A kind of pharmaceutical composition for the treatment of hyperglycemia hyperlipidemia | |
| CN103157069B (en) | Miao medicament for treating cholecystitis | |
| CN102631498B (en) | Chinese medicine composition | |
| CN107714820B (en) | A kind of pharmaceutical composition for treating allergic rhinitis and its preparation method and use | |
| CN104435437B (en) | A kind ofly treat Chinese medicine of the concurrent glossopharyngeal neuralgia of trigeminal neuralgia and preparation method thereof | |
| CN104740579B (en) | Premenstrual peace piece and its preparation technology | |
| CN100512854C (en) | Medicine composition for treating digestive exulceratio | |
| CN1174773C (en) | Medicament for treating digestive tract diseases and preparation method thereof | |
| CN118477132B (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN115624586B (en) | A traditional Chinese medicine composition for treating hormone-dependent asthma and its application | |
| CN102727730B (en) | Traditional Chinese medicinal compound preparation for treating male infertility and its preparation method | |
| CN103933476B (en) | It is a kind of to treat pharmaceutical composition of intercostal neuralgia and its production and use | |
| CN109010621A (en) | A kind of Chinese medicine composition that treating diabetes, preparation method and applications | |
| CN103705631B (en) | Gegenjiangtang capsules and preparation method | |
| CN106344758A (en) | Lam's sugar reducing formula | |
| CN100486612C (en) | Soft capsule containing Bupleurum and Radix scutellariae, preparation method and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170511 Address after: 226000, No. 1, Zhenxing Town, Donghai Town, Nantong City, Jiangsu, Qidong Patentee after: QIDONG CIYT XINZAO CASTING FACTORY Address before: 276600 Junan County People's Hospital, 156 Tianqiao Road, Junan County, Shandong, Linyi Patentee before: Wang Yongcui |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220524 Address after: 226200 Donghai Zhen Zhong Hui Cun, Qidong City, Nantong City, Jiangsu Province Patentee after: Qidong Ourui Food Co.,Ltd. Address before: 226000 No.1, xingken Town, Donghai Town, Qidong City, Nantong City, Jiangsu Province Patentee before: QIDONG CIYT XINZAO CASTING FACTORY |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150812 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |